If you liked this article you might like

Celgene Can't Expand Revlimid Approval into Non-Hodgkin Lymphoma Just Yet

Celgene Can't Expand Revlimid Approval into Non-Hodgkin Lymphoma Just Yet

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

Gilead Lowers Product Sales Guidance on Weak Hepatitis C Sales

PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe

PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership